您当前的位置:首页 > 主题内容 > 临床麻醉 > 专家评述
Methods The cultured HUVECs were randomly divided into ten groups: control group(group C,RPMI-1640),LPS group(group L,LPS 1μg/ml),ketamine group(group K,and divided into KⅠ-KⅣ according the varying concentrations of ketamine,ketamine 12.5、25.0、100、300μmol/L +LPS 1μg/ml),MK-801 group(group M,and divided into MⅠ-MⅣ according the different concentrations of MK-801,MK-801 1.25、2.50、10、30μmol/L +LPS 1μg/ml). After 18h of incubation at 37℃ in a 95% air / 5% CO2 incubator , the HUVECs were harvested for flow cytometric analysis of ICAM-1. In another set of experiments, the cultured HUVECs were stimulated with LPS 1μg/ml for 2 hours in the absence or presence of ketamine(12.5, 25.0, 100 and 300μmol/L) or MK-801(1.25, 2.50, 10 and 30μmol/L). The translocation of NF-κB p65 into nuclei was stained with immunohistochemistry (Streptavidin/Peroxidase)technique. Results Group KⅡ、KⅢ、KⅣsignificantly reduced the up-regulation of ICAM-1 and the translocation of NF-κB into nuclei of HUVECs caused by LPS(P<0.05),and there was positive correlation between them(r=0.985, P<0.01). Group MⅠ、MⅡ、MⅢ、MⅣ had no effect on the expression of ICAM-1 and the translocation of NF-κB into nuclei(P>0.05). Conclusions At the higher concentrations(≥25μmol/L), ketamine could suppressed LPS induced HUVECs activation. The inhibitory effects of ketamine is most likely not mediated through NMDA receptor interactions.
近年研究发现,氯胺酮(ketamine)可以抑制炎症反应中白细胞的活化[1]。但氯胺酮是否能影响内皮细胞的活化尚无定论[2,3],其抗炎作用的确切机制也不清楚。本实验拟采用脂多糖(lipopolysaccharide,LPS)刺激人脐静脉内皮细胞(human umbilical vein endothelial cells, HUVECs)模拟体内的炎症反应过程,通过检测HUVECs胞间黏附分子-1(intercellular adhesion molecule-1, ICAM-1)表达及核因子-kappa B (nuclear factor-kappa B,NF-κB)易位活化的变化,观察氯胺酮及MK-801对炎症反应中内皮细胞活化的影响,初步探讨其抗炎机制。 材料与方法 试剂与仪器 RPMI-1640培养液、LPS、MK-801(Sigma,美国);氯胺酮(江苏恒瑞医药股份有限公司,批号011110);ICAM-1 FITC标记单克隆抗体、IgG1同型对照抗体(Immunotech Coulter,美国);NF-κB p65单克隆抗体、过氧化物酶标记的链霉卵白素染色试剂盒(北京中山生物技术有限公司)。Olympus CK 40显微镜(日本);EPICS-XL Bechman Coulter流式细胞仪(美国)。 HUVECs的培养 参照Jaffe[4]的方法。取新鲜脐带,注入0.1%Ⅰ型胶原酶消化内皮细胞,培养于20%胎牛血清、100ku/L青霉素G、100mg/L链霉素、90mg/L肝素的RPMI-1640培养液中,置入37℃、5%CO2培养箱中,约7d长成单层,传代后用于实验。 ICAM-1表达的测定 体外培养的HUVECs随机分为十组,(每组细胞孔数 n=8):对照组(C组,RPMI-1640)、LPS组(L组,LPS 1μg/ml)、氯胺酮组(K组,依浓度不同分为KⅠ、KⅡ、KⅢ、KⅣ亚组,即Ketamine 12.5、25.0、100、300μmol/L + LPS 1μg/ml)、MK-801组(M组,依浓度不同分为MⅠ、MⅡ、MⅢ、MⅣ亚组,即MK-801 1.25、2.50、10、30μmol/L + LPS 1μg/ml)。K组和M组各组加入不同浓度的氯胺酮或MK-801后,在37℃、5%CO2培养箱中孵育30min,再加入LPS 1μg/ml,放入培养箱中孵育18h;L组不加入氯胺酮或MK-801,仅在孵育30min后加入LPS 1μg/ml作用18h;而C组在孵育30min后加入与LPS等体积的RPMI-1640作用18h。随后每孔中加入0.25%胰酶-0.2% EDTA消化贴壁的内皮细胞,将细胞清洗后每份样品中加入FITC标记的ICAM-1单克隆抗体20μl,4℃下避光30min,同时设立同型对照,每份加入FITC标记的IgG1单克隆抗体20μl。用流式细胞仪(EPICS-XL Bechman Coulter,美国)检测ICAM-1的表达。 NF-κB p65表达的测定 实验分组方法同上。K组和M组每组加入不同浓度的氯胺酮或MK-801,在37℃、5%CO2培养箱中孵育30min,再加入LPS 1μg/ml孵育2h;L组仅在孵育30min后,加入LPS 1μg/ml作用2h;而C组在孵育30min后,加入与LPS等体积的RPMI-1640作用2h。用免疫组化(SP)方法测定内皮细胞中NF-κB p65亚基的表达。在200×高倍视野中每个培养孔随机选取10个视野,计算阳性细胞在整个视野所有细胞中所占比例。采用双盲法以减少人为误差。单位以百分率(%)表示。 参考文献 1 Weigand MA, Schmidt H, Zhao Q, et al. Ketamine modulates the stimulated adhesion molecule expression on human neutrophils in vitro. Anesth Analg, 2000, 90: 206-212. 2 Zahler S, Heindl B, Becker BF. Ketamine does not inhibit inflammatory responses of cultured human endothelial cells but reduces chemotactic activation of neutrophils. Acta Anaesthesiol Scand, 1999, 43: 1011-1016. 3 Hofbauer R, Moser D, Salfinger H, et al. Sufentanil inhibits migration of human leukocytes through human endothelial cell monolayers. Anesth Analg, 1998, 87: 1181-1185. 4 Jaffe EA. Biology of endothelial cells. Boston: Martinus Nijhoff Publishers, 1984. 2-8. 5 Carlos TM, Harlan JM. Leukocyte-endothelial adhesion molecules. Blood, 1994, 84(7): 2068-2101. 6 Valen G, Yan Z, Hansson GK. Nuclear factor kappa-B and the heart. J Am Coll Cardiol, 2001, 38(2): 307-314. 7 Tokuyasu H, Tomita K, Hitsuda Y. An inhibitory effect of dexamethasone on A549 cell adhesion to neutrophils: possible involvement of nuclear factor-kappa B. Yonago Acta medica, 1999, 42: 11-20. 8 Roytblat L, Talmor D, Rachinsky M, et al. Ketamine attenuates the interleukin-6 response after cardiopulmonary bypass. Anesth Analg, 1998, 87: 266-271. 9 Kawasaki T, Ogata M, Kawasaki C, et al. Ketamine suppresses proinflammatory cytokine production in human whole blood in vitro. Anesth Analg, 1999, 89: 665-669. |
|
|